« Back to Record
Citation APA

Ponde, N., Bradbury, I., Lambertini, M., Ewer, M. S., Campbell, C., Ameels, H., Zardavas, D., Di Cosimo, S., Baselga, J., Huober, J., Izquierdo, M., Fumagalli, D., Bozovic-Spasojevic, I., Maetens, M. M., Harbeck, N., Pusztai, L., Berghorn, M., Im, Y. H., Borrego, M. R., Chen, D.-R., Rodeheffer, R., Piccart-Gebhart, M., Suter, T., & de Azambuja, E. (2017). Cardiac biomarkers for early detection and prediction of trastuzumab and/or lapatinib-induced cardiotoxicity in patients with HER2-positive early-stage breast cancer: a NeoALTTO sub-study (BIG 1-06). Breast cancer research and treatment. doi:10.1007/s10549-017-4628-3


Permalink

http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/265787

Ponde, N., Bradbury, I., Lambertini, M., Ewer, M. S., Campbell, C., Ameels, H., Zardavas, D., Di Cosimo, S., Baselga, J., Huober, J., Izquierdo, M., Fumagalli, D., Bozovic-Spasojevic, I., Maetens, M. M., Harbeck, N., Pusztai, L., Berghorn, M., Im, Y. H., Borrego, M. R., Chen, D.-R., Rodeheffer, R., Piccart-Gebhart, M., Suter, T., & de Azambuja, E. (2017). Cardiac biomarkers for early detection and prediction of trastuzumab and/or lapatinib-induced cardiotoxicity in patients with HER2-positive early-stage breast cancer: a NeoALTTO sub-study (BIG 1-06). Breast cancer research and treatment. doi:10.1007/s10549-017-4628-3